Compounds > fluorouracil

fluorouracil and tilorone

fluorouracil has been researched along with tilorone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Lin, PZ1
Cai, HY; Li, MX; Lin, PZ; Liu, SF; Shu, YJ; Wang, GQ; Wu, AR1

Other Studies

5 other study(ies) available for fluorouracil and tilorone

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
[Treatment of marked epithelial dysplasia of esophagus. II. Microspectophotometric studies on DNA content in epithelial cells of esophagus treated with antitumor B III or tilorone (author's transl)].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1981, Volume: 3, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; DNA, Neoplasm; Drug Combinations; Drugs, Chinese Herbal; Epithelium; Esophageal Neoplasms; Esophagus; Fluorenes; Fluorouracil; Humans; Plant Extracts; Precancerous Conditions; Spectrophotometry; Tilorone

1981
[Therapy of severe epithelial dysplasia of esophagus. I. Therapeutic effects of Antitumor B III, Antitumor B and tilorone (author's transl)].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1980, Volume: 2, Issue:2

    Topics: Adult; Animals; Antineoplastic Agents, Phytogenic; Drug Combinations; Drugs, Chinese Herbal; Esophageal Diseases; Esophageal Neoplasms; Female; Fluorenes; Fluorouracil; Humans; Male; Mice; Middle Aged; Phytotherapy; Plant Extracts; Plants, Medicinal; Precancerous Conditions; Tilorone

1980